Medical research
Nanotherapeutic that can cross blood-brain barrier
The University of Delaware's Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier.
Nov 25, 2013
0
0
News tagged with malignant tumor
Oncology & Cancer
Doubling forces against glioblastomas: Two-drug combination slows malignant brain tumors in mice
(Medical Xpress)—A novel combination of two oral targeted drugs dramatically slowed the growth of glioblastoma brain tumors in mice and significantly extended the animals' survival, report scientists at Harvard Medical ...
Oct 25, 2013
0
0
Oncology & Cancer
New clue to aggressive brain tumors
(Medical Xpress)—Scientists at Washington University School of Medicine in St. Louis have identified a biological marker that may help predict survival in people with deadly brain tumors. The researchers showed that when ...
Oct 21, 2013
0
0
Oncology & Cancer
Disabling enzyme reduces tumor growth, cripples cancer cells
Knocking out a single enzyme dramatically cripples the ability of aggressive cancer cells to spread and grow tumors, offering a promising new target in the development of cancer treatments, according to a new study by researchers ...
Aug 26, 2013
0
0
Oncology & Cancer
Brain cancer: Hunger for amino acids makes it more aggressive
An enzyme that facilitates the breakdown of specific amino acids makes brain cancers particularly aggressive. Scientists from the German Cancer Research Center discovered this in an attempt to find new targets for therapies ...
Jun 24, 2013
0
0
Genetics
Aspirin may fight cancer by slowing DNA damage
Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...
Jun 18, 2013
0
0
Oncology & Cancer
Oncogene mutation hijacks splicing process to promote growth and survival
An international team of researchers – led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, ...
May 31, 2013
0
0
Oncology & Cancer
Researchers discover brain cancer treatment using genetic material from bone marrow cells
In a first-of-its-kind experiment using microvesicles generated from mesenchymal bone marrow cells (MSCs) to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of ...
Apr 1, 2013
0
0
Oncology & Cancer
Immortality gene mutation identifies brain tumors, other cancers
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research ...
Mar 18, 2013
0
0
Oncology & Cancer
BRAF inhibitor treatment causes melanoma cells to shift how they produce energy
A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings, ...
Mar 8, 2013
0
0
